Syndecan-4 promotes cytokinesis in a phosphorylation-dependent manner in MCF-7 breast adenocarcinoma cells, which shed the ectodomain of syndecan-4 periodically in a cell cycle-dependent way, reaching the maximum at the G2/M phase [126]. Here, SDC4 is linked to breast adenocarcinoma.